A Prospective Study Using Validated Outcome Instruments For Platelet Rich Plasma Therapy for Facial Rejuvenation
Sammy Sinno, MD, Grace Poudrier, B.A., Jennifer Thompson, B.S., Z-hye Lee, M.D., Michael V. Chiodo, M.D., Alexes Hazen, M.D..
New York University, New York, NY, USA.
Platelet rich plasma (PRP) therapy can be used for facial rejuvenation. To date, the efficacy and degree of patient satisfaction following PRP treatment has not been evaluated in a standardized fashion with validated patient outcome tools.br>
25 patients were selected for PRP therapy for facial rejuvenation. All patients completed the following FACE-Q scales pre-procedure: appearance appraisal, quality of life, adverse effect checklists for treatment, and process of care. PRP was prepared using a standardized protocol. At 6 weeks post-treatment, another FACE-Q was completed and 2 blinded observers (one plastic surgeon and one dermatologist) were asked to evaluate results, including completion of the Wrinkle Severity Rating Scale.
All of the patients in this study were female. Compared to pre-procedure FACE-Q scores, patients had higher degrees of satisfaction with appearance appraisal, quality of life, and process of care post-procedure. There were no reported complications. An improvement in Wrinkle Severity Rating was noted between pre- and post-treatment (p<0.05).
This is the first study to use validated instruments to demonstrate the effectiveness of PRP therapy for facial rejuvenation.
Back to 2016 Annual Meeting Posters